Marco Investment Management LLC Sells 825 Shares of CVS Health Co. (NYSE:CVS)

Marco Investment Management LLC lessened its holdings in shares of CVS Health Co. (NYSE:CVS) by 1.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 75,511 shares of the pharmacy operator’s stock after selling 825 shares during the quarter. Marco Investment Management LLC’s holdings in CVS Health were worth $3,390,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in CVS. Hotchkis & Wiley Capital Management LLC raised its stake in CVS Health by 34.8% during the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 11,897,034 shares of the pharmacy operator’s stock valued at $748,085,000 after purchasing an additional 3,071,613 shares during the period. Raymond James Financial Inc. bought a new stake in CVS Health in the 4th quarter worth approximately $116,033,000. ARGA Investment Management LP increased its stake in CVS Health by 7,567.7% in the 4th quarter. ARGA Investment Management LP now owns 2,402,901 shares of the pharmacy operator’s stock worth $107,866,000 after acquiring an additional 2,371,563 shares during the last quarter. State Street Corp increased its stake in CVS Health by 3.6% in the 3rd quarter. State Street Corp now owns 56,527,909 shares of the pharmacy operator’s stock worth $3,554,475,000 after acquiring an additional 1,989,066 shares during the last quarter. Finally, TOMS Capital Investment Management LP bought a new stake in CVS Health in the 3rd quarter worth approximately $121,987,000. Institutional investors own 80.66% of the company’s stock.

CVS Health Price Performance

CVS opened at $65.17 on Friday. The business has a fifty day moving average of $55.98 and a 200 day moving average of $56.69. CVS Health Co. has a 52-week low of $43.56 and a 52-week high of $80.75. The company has a quick ratio of 0.60, a current ratio of 0.81 and a debt-to-equity ratio of 0.80. The stock has a market cap of $82.16 billion, a P/E ratio of 17.80, a PEG ratio of 0.98 and a beta of 0.61.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share for the quarter, topping the consensus estimate of $0.89 by $0.30. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. As a group, sell-side analysts anticipate that CVS Health Co. will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd were issued a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 4.08%. The ex-dividend date of this dividend was Thursday, January 23rd. CVS Health’s dividend payout ratio is 72.68%.

Analysts Set New Price Targets

A number of analysts have issued reports on the company. UBS Group reduced their price objective on CVS Health from $62.00 to $59.00 and set a “neutral” rating on the stock in a research note on Tuesday, February 11th. Deutsche Bank Aktiengesellschaft raised CVS Health from a “hold” rating to a “buy” rating and set a $66.00 price objective on the stock in a research note on Tuesday, December 3rd. Wolfe Research lifted their price objective on CVS Health from 67.00 to 70.00 and gave the stock an “overweight” rating in a research note on Tuesday, February 11th. StockNews.com raised CVS Health from a “sell” rating to a “hold” rating in a research report on Thursday, February 13th. Finally, JPMorgan Chase & Co. boosted their target price on CVS Health from $80.00 to $81.00 and gave the company an “overweight” rating in a research report on Tuesday, February 18th. Four analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, CVS Health has an average rating of “Moderate Buy” and an average price target of $69.83.

Insiders Place Their Bets

In other news, Director Michael F. Mahoney bought 30,000 shares of the stock in a transaction on Tuesday, February 18th. The stock was acquired at an average cost of $66.70 per share, for a total transaction of $2,001,000.00. Following the acquisition, the director now owns 39,356 shares of the company’s stock, valued at $2,625,045.20. This represents a 320.65 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 0.24% of the company’s stock.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.